Literature DB >> 19575260

Is there a difference in gastric emptying between Parkinson's disease patients under long-term L-dopa therapy with and without motor fluctuations? An analysis using the 13C-acetate breath test.

Yuji Tanaka1, Tomohiro Kato, Hiroshi Nishida, Hiroshi Araki, Masahiko Murase, Masahito Nagaki, Hisataka Moriwaki, Takashi Inuzuka.   

Abstract

The mechanism underlying the motor fluctuations that develop after long-term L-dopa therapy is not fully known. It has been speculated that malabsorption of L-dopa from the small intestine occurs. It was reported that gastric retention in Parkinson's disease (PD) patients with motor fluctuations is increased as compared with that in PD without fluctuations. Because L-dopa therapy may worsen the symptoms of delayed gastric emptying (GE), it was not clear whether the delayed GE of PD patients with motor fluctuation was affected by L-dopa therapy. We assessed GE in PD patients with and without motor fluctuations. We investigated GE in 40 patients with PD under long-term L-dopa therapy, 20 fluctuators with "delayed-on" and "noon" phenomena, 20 nonfluctuators, and 20 healthy volunteers. GE was examined by the 13C-acetate breath test ((13)CABT) [the half emptying time (HET), the peak time of the (13)C-%-dose-excess curve (T(max))], with expirations collected for 4 h after a test meal and analyzed for (13)CO(2) using an infrared (IR) spectrophotometer. The T(max) of GE as assessed using the (13)C-ABT was significantly delayed in all PD patients as compared with controls (P = 0.002). The HET was significantly delayed in all PD patients as compared with controls (P < 0.001). The T(max) and HET were not significantly delayed in PD patients with motor fluctuations as compared with PD patients without motor fluctuations. These results demonstrated that GE is commonly delayed in PD patients with long-term L-dopa therapy. Delayed GE does not differ between PD patients with and without motor fluctuations. This finding demonstrated that the motor fluctuation in PD may not be influenced by GE.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19575260     DOI: 10.1007/s00415-009-5220-5

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  24 in total

1.  Patterns of clinical response and plasma dopa levels in Parkinson's disease.

Authors:  E S Tolosa; W E Martin; H P Cohen; R L Jacobson
Journal:  Neurology       Date:  1975-02       Impact factor: 9.910

2.  Parkinson's disease and megacolon: concentric hyaline inclusions (Lewy bodies) in enteric ganglion cells.

Authors:  W J Kupsky; M M Grimes; J Sweeting; R Bertsch; L J Cote
Journal:  Neurology       Date:  1987-07       Impact factor: 9.910

3.  Parkinson's disease: the presence of Lewy bodies in Auerbach's and Meissner's plexuses.

Authors:  K Wakabayashi; H Takahashi; S Takeda; E Ohama; F Ikuta
Journal:  Acta Neuropathol       Date:  1988       Impact factor: 17.088

4.  Gastric emptying time and gastric motility in patients with Parkinson's disease.

Authors:  R Hardoff; M Sula; A Tamir; A Soil; A Front; S Badarna; S Honigman; N Giladi
Journal:  Mov Disord       Date:  2001-11       Impact factor: 10.338

5.  Parkinsonism: onset, progression and mortality.

Authors:  M M Hoehn; M D Yahr
Journal:  Neurology       Date:  1967-05       Impact factor: 9.910

6.  Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases.

Authors:  A J Hughes; S E Daniel; L Kilford; A J Lees
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-03       Impact factor: 10.154

Review 7.  Gastrointestinal dysfunction in Parkinson's disease: frequency and pathophysiology.

Authors:  L L Edwards; E M Quigley; R F Pfeiffer
Journal:  Neurology       Date:  1992-04       Impact factor: 9.910

8.  Gastric electromechanical dysfunction in Parkinson's disease.

Authors:  A Krygowska-Wajs; K Lorens; P Thor; A Szczudlik; S Konturek
Journal:  Funct Neurol       Date:  2000 Jan-Mar

Review 9.  The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease.

Authors:  W R Gibb; A J Lees
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-06       Impact factor: 10.154

10.  Measurement of gastric emptying rate of solids by means of a carbon-labeled octanoic acid breath test.

Authors:  Y F Ghoos; B D Maes; B J Geypens; G Mys; M I Hiele; P J Rutgeerts; G Vantrappen
Journal:  Gastroenterology       Date:  1993-06       Impact factor: 22.682

View more
  9 in total

Review 1.  Parkinson's disease and 2009: recent advances.

Authors:  David P Breen; Roger A Barker
Journal:  J Neurol       Date:  2010-04-08       Impact factor: 4.849

2.  Mice overexpressing wild-type human alpha-synuclein display alterations in colonic myenteric ganglia and defecation.

Authors:  L Wang; I Magen; P-Q Yuan; S R Subramaniam; F Richter; M-F Chesselet; Y Taché
Journal:  Neurogastroenterol Motil       Date:  2012-07-11       Impact factor: 3.598

3.  Unchanged gastric emptying and visceral perception in early Parkinson's disease after a high caloric test meal.

Authors:  L Epprecht; S R Schreglmann; O Goetze; D Woitalla; C R Baumann; D Waldvogel
Journal:  J Neurol       Date:  2015-06-06       Impact factor: 4.849

4.  Is there delayed gastric emptying in patients with multiple system atrophy? An analysis using the (13)C-acetate breath test.

Authors:  Yuji Tanaka; Tomohiro Kato; Hiroshi Nishida; Megumi Yamada; Akihiro Koumura; Takeo Sakurai; Yuichi Hayashi; Akio Kimura; Isao Hozumi; Hiroshi Araki; Masahiko Murase; Masahito Nagaki; Hisataka Moriwaki; Takashi Inuzuka
Journal:  J Neurol       Date:  2012-01-05       Impact factor: 4.849

5.  Is there a delayed gastric emptying of patients with early-stage, untreated Parkinson's disease? An analysis using the 13C-acetate breath test.

Authors:  Yuji Tanaka; Tomohiro Kato; Hiroshi Nishida; Megumi Yamada; Akihiro Koumura; Takeo Sakurai; Yuichi Hayashi; Akio Kimura; Isao Hozumi; Hiroshi Araki; Masahiko Murase; Masahito Nagaki; Hisataka Moriwaki; Takashi Inuzuka
Journal:  J Neurol       Date:  2010-10-12       Impact factor: 4.849

6.  Is there a difference in gastric emptying between myotonic dystrophy type 1 patients with and without gastrointestinal symptoms?

Authors:  Yuji Tanaka; Tomohiro Kato; Hiroshi Nishida; Megumi Yamada; Akihiro Koumura; Takeo Sakurai; Yuichi Hayashi; Akio Kimura; Isao Hozumi; Hiroshi Araki; Masahiko Murase; Masahito Nagaki; Hisataka Moriwaki; Takashi Inuzuka
Journal:  J Neurol       Date:  2013-01-24       Impact factor: 4.849

7.  A rapid non invasive L-DOPA-¹³C breath test for optimally suppressing extracerebral AADC enzyme activity - toward individualizing carbidopa therapy in Parkinson’s disease.

Authors:  Anil Modak; Raymon Durso; Ephraim Josephs; David Rosen
Journal:  J Parkinsons Dis       Date:  2012       Impact factor: 5.568

8.  Impact of Residual Drug in the Pharynx on the Delayed-On Phenomenon in Parkinson's Disease Patients.

Authors:  Jiro Fukae; Shinsuke Fujioka; George Umemoto; Hajime Arahata; Shosaburo Yanamoto; Takayasu Mishima; Yoshio Tsuboi
Journal:  Mov Disord Clin Pract       Date:  2020-02-27

9.  Serum metabolic biomarkers for synucleinopathy conversion in isolated REM sleep behavior disorder.

Authors:  Ariadna Laguna; Helena Xicoy; Eduardo Tolosa; Mònica Serradell; Dolores Vilas; Carles Gaig; Manel Fernández; Oscar Yanes; Joan Santamaria; Núria Amigó; Alex Iranzo; Miquel Vila
Journal:  NPJ Parkinsons Dis       Date:  2021-05-13
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.